10x Genomics to Acquire Scale Biosciences for Single Cell Analysis Expansion
10x Genomics, a leader in single cell and spatial biology, is set to acquire Scale Biosciences, a company known for innovative and scalable single cell analysis. This acquisition aims to enhance the capabilities of 10x Genomics’ Chromium platform, making single cell analysis more accessible to researchers globally. The deal will support a product roadmap focused on scaling the number of cells and samples analyzed while maintaining the multiomic data quality expected from 10x.
Scale Biosciences: Pioneering Scalable Single Cell Analysis
Scale Biosciences, founded by a team of experts in next generation sequencing, genomics, and bioinformatics, has made significant advancements in scalable single cell analysis through combinatorial indexing and quantum barcoding. The company’s scientific founders, including prominent professors from Stanford University and the University of Washington, are joining 10x as advisors. Led by President and CEO Giovanna Prout, Scale Biosciences brings valuable expertise to 10x Genomics’ portfolio.
10x Genomics: Revolutionizing Life Science Technology
Under the leadership of CEO Serge Saxonov, 10x Genomics is dedicated to accelerating biological research and improving human health through innovative technology. The company’s integrated solutions for single cell and spatial biology empower researchers and biopharmaceutical companies to understand complex biological systems with unprecedented resolution and scale. 10x Genomics will continue to support Scale Biosciences’ customers and initiatives, ensuring key products remain available in the market.
